Verdiva Bio
Series ALondon, UKJan 2025
Verdiva Bio raised €399M in a Series A round in Jan 2025. The company is based in London, UK. Investors in the round: Forbion, General Atlantic, Lilly Asia Ventures and 4 others. Data as of 4 Nov 2026.
Amount raised
€399M
€398,874,224
Native amount
411,000,000 USD
Stage
Series A
series a
Investors
7
Provenance & confidence
High confidenceAmount
411,000,000 USD
ECB-at-date → €399M · rate 1.0304 on 2025-01-10
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedDate
Jan 2025
Round type
series a
Amount (EUR)
€399M
Other rounds
same companyThis is the company's only recorded round.